Affimed NV
NASDAQ:AFMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Affimed NV
NASDAQ:AFMD
|
DE |
|
H
|
Horizon Therapeutics PLC
F:HPR
|
IE |
|
Consolidated Lithium Metals Inc
XTSX:CLM
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AFMD's stock price target?
Not Available
AFMD doesn't have any price targets made by Wall Street professionals.
What is Affimed NV's Revenue forecast?
Projected CAGR
14%
For the last 10 years the
compound annual growth rate for
Affimed NV's revenue is
5%.
The projected
CAGR
for the next 4 years is
14%.